These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 1531763)
1. IL-7 induces proliferation of CD3-/low CD4- CD8- human thymocyte precursors by an IL-2 independent pathway. Fabbi M; Groh V; Strominger JL Int Immunol; 1992 Jan; 4(1):1-5. PubMed ID: 1531763 [TBL] [Abstract][Full Text] [Related]
2. Purified human T cells stimulated with cross-linked anti-CD3 monoclonal antibody OKT3: rIL-1 is a co-stimulatory factor for CD4+CD29+CD45RA- T cells. Panzer S; Geller RL; Bach FH Scand J Immunol; 1990 Oct; 32(4):359-71. PubMed ID: 1700468 [TBL] [Abstract][Full Text] [Related]
3. Identification of a novel human thymocyte subset with a phenotype of CD3- CD4+ CD8 alpha + beta-1. Possible progeny of the CD3- CD4- CD8- subset. Hori T; Cupp J; Wrighton N; Lee F; Spits H J Immunol; 1991 Jun; 146(12):4078-84. PubMed ID: 1828260 [TBL] [Abstract][Full Text] [Related]
4. Growth-promoting activity of IL-1 alpha, IL-6, and tumor necrosis factor-alpha in combination with IL-2, IL-4, or IL-7 on murine thymocytes. Differential effects on CD4/CD8 subsets and on CD3+/CD3- double-negative thymocytes. Suda T; Murray R; Guidos C; Zlotnik A J Immunol; 1990 Apr; 144(8):3039-45. PubMed ID: 1969882 [TBL] [Abstract][Full Text] [Related]
5. Independent expression of p55 and p75 interleukin-2 receptors (IL-2R) during intravenous or subcutaneous administration of recombinant interleukin-2 (rIL-2) by T-lymphocytes and natural killer cells. Zambello R; Trentin L; Cerutti A; Enthammer C; Milani A; Franceschi T; Messina C; Cetto GL; Agostini C; Semenzato G Cancer; 1994 Nov; 74(9):2562-9. PubMed ID: 7522954 [TBL] [Abstract][Full Text] [Related]
6. In vitro induction of CD8 expression on thymic pre-T cells. I. Transforming growth factor-beta and tumor necrosis factor-alpha induce CD8 expression on CD8- thymic subsets including the CD25+CD3-CD4-CD8- pre-T cell subset. Suda T; Zlotnik A J Immunol; 1992 Mar; 148(6):1737-45. PubMed ID: 1347307 [TBL] [Abstract][Full Text] [Related]
7. IL-7 maintains the T cell precursor potential of CD3-CD4-CD8- thymocytes. Suda T; Zlotnik A J Immunol; 1991 May; 146(9):3068-73. PubMed ID: 1826704 [TBL] [Abstract][Full Text] [Related]
8. Role of IL-2, IL-4 and IL-6 in the growth and differentiation of tumor-specific CD4+ T helper and CD8+ T cytotoxic cells. Selvan RS; Nagarkatti PS; Nagarkatti M Int J Cancer; 1990 Jun; 45(6):1096-104. PubMed ID: 1972141 [TBL] [Abstract][Full Text] [Related]
9. The kinetics of immature murine thymocyte development in vivo. Egerton M; Shortman K; Scollay R Int Immunol; 1990; 2(6):501-7. PubMed ID: 2128186 [TBL] [Abstract][Full Text] [Related]
10. Phorbol myristate acetate-induced expression of high-affinity interleukin 2 receptors and production of interleukin 2 by human acute lymphoblastic leukemia T cells. Sahraoui Y; Allouche M; Perrakis M; Clemenceau C; Jasmin C; Georgoulias V Leukemia; 1992 Apr; 6(4):295-303. PubMed ID: 1588792 [TBL] [Abstract][Full Text] [Related]
11. IL-7 is a growth and maintenance factor for mature and immature thymocyte subsets. Murray R; Suda T; Wrighton N; Lee F; Zlotnik A Int Immunol; 1989; 1(5):526-31. PubMed ID: 2518727 [TBL] [Abstract][Full Text] [Related]
12. In vitro expansion of tumor-specific, HLA-restricted human CD8+ cytolytic T lymphocytes. Nakashima M; Watanabe T; Koprowski H; Schuchter L; Steplewski Z Cell Immunol; 1994 Apr; 155(1):53-61. PubMed ID: 7513262 [TBL] [Abstract][Full Text] [Related]
13. Impairment of CD3-dependent and CD3-independent activation pathways in CD4+ and in CD8+ T cells from old CBA/RIJ mice. Hertogh-Huijbregts A; Vissinga C; Rozing J; Nagelkerken L Mech Ageing Dev; 1990 Apr; 53(2):141-55. PubMed ID: 1971316 [TBL] [Abstract][Full Text] [Related]
14. The effects of interleukin 2 on early and late thymocyte differentiation in foetal thymus organ culture. Waanders GA; Boyd RL Int Immunol; 1990; 2(5):461-8. PubMed ID: 2128184 [TBL] [Abstract][Full Text] [Related]
15. Subpopulations of fetal thymocytes defined by expression of T cell receptor/CD3 and IL-2 receptor. CD3 and IL-2 receptor alpha-chain are expressed on reciprocal cell populations. Guy R; Foo-Philips M; Sharrow SO; Hodes RJ J Immunol; 1991 Jan; 146(2):418-24. PubMed ID: 1824773 [TBL] [Abstract][Full Text] [Related]
16. Lineage relationships and developmental kinetics of immature thymocytes: CD3, CD4, and CD8 acquisition in vivo and in vitro. Petrie HT; Hugo P; Scollay R; Shortman K J Exp Med; 1990 Dec; 172(6):1583-8. PubMed ID: 2147945 [TBL] [Abstract][Full Text] [Related]
18. Different sensitivity to interleukin 4 of interleukin 2- and interferon alpha-induced CD69 antigen expression in human resting NK cells and CD3+, CD4-, CD8- lymphocytes. Gerosa F; Tommasi M; Carra G; Gandini G; Tridente G; Benati C Cell Immunol; 1992 May; 141(2):342-51. PubMed ID: 1533569 [TBL] [Abstract][Full Text] [Related]
19. In vitro effects of recombinant interleukin 7 on growth and differentiation of bone marrow pro-B- and pro-T-lymphocyte clones and fetal thymocyte clones. Takeda S; Gillis S; Palacios R Proc Natl Acad Sci U S A; 1989 Mar; 86(5):1634-8. PubMed ID: 2784210 [TBL] [Abstract][Full Text] [Related]
20. Selective stimulation of thymocyte precursors mediated by specific cytokines. Different CD3+ subsets are generated by IL-1 versus IL-2. Gotlieb WH; Durum SK; Gregorio TA; Mathieson BJ J Immunol; 1991 Apr; 146(7):2262-71. PubMed ID: 1706392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]